Showing results (31-40 of 8,245) with videos related to
Sort By:
Pageof 825
Medical Oncology (Northwood, London, England)|April 28, 2022
Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growthArshak R Alexanian, Avonlea BrannonOrganic Letters|November 6, 2019
Manganese-Catalyzed Stereospecific Hydroxymethylation of Alkyl TosylatesHannah Shenouda, Erik J AlexanianJournal of Tissue Engineering and Regenerative Medicine|June 8, 2012
The neural plasticity of early-passage human bone marrow-derived mesenchymal stem cells and their modulation with chromatin-modifying agentsZhiying Zhang, Arshak R AlexanianJournal of Cellular and Molecular Medicine|June 12, 2012
Dopaminergic-like cells from epigenetically reprogrammed mesenchymal stem cellsZhiying Zhang, Arshak R AlexanianThe Journal of Clinical Investigation|August 11, 2020
BETs that cover the spread from acquired to heritable heart failureMichael Alexanian, Saptarsi M HaldarFrontiers in Rehabilitation Sciences|October 3, 2022
Virtual reality and music's impact on psychological well-beingStephen Alexanian, Maxwell Foxman, Danny PimentelInvestigational New Drugs|January 19, 2000
Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2)A R Alexanian, N S ArutyunianSeminars in Hematology|August 7, 2001
Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experienceJ Crowley, J Jacobson, R AlexanianTetrahedron|August 14, 2019
Nickel-catalyzed, ring-forming aromatic C-H alkylations with unactivated alkyl halidesQuentin D Tercenio, Erik J AlexanianPageof 825